FDA Investigator Obinna R Echeozo
Obinna R Echeozo has inspections in 2 countries as of 21 Sep 2023. Obinna R Echeozo has collaborated with a combined 1084 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
France
Co-Investigator(s):
Andrey Sarafanov, PhD,
Anissa M Cheung,
Arulvathani P Arudchandran,
Ben A Firschein,
Bo Chi, PhD,
Brenda W Uratani, PhD,
Candace Y Gomez Broughton,
Carl A Perez,
Christian D Lynch (CDL),
Daniel L Zheng,
Donald C Obenhuber, PhD,
Dr. Robert C Horan, MD,
Ellen Huang,
Ellen P Madigan,
Erik W Koester,
Hector A Carrero,
Jacek Cieslak, PhD,
Jie He,
John P Mistler,
John S Hartford,
Jonathan G Matrisciano,
Kalavati Suvarna, PhD,
Kathleen R Jones, PhD,
L Norwood,
Laurie Graham,
LCDR Debra Emerson,
Linda Thai,
Lori A Holmquist,
M Pedgen,
Malgorzata G Norton,
Mariza M Jafary,
Marlene G Swider,
Mary Jeanet Mcgarry,
Megan A Haggerty,
Michael C Kennedy, PhD,
Michele L Forster, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mindy M Chou,
Nicole M Li,
Pankaj H Amin,
Patricia Fhughes Troost,
Pete Amin (Pankaj),
Rajiv R Srivastava,
Ramon E Martinez,
Ranjani Prabhakara,
Rashmi Rawat, PhD,
Robert J Martin,
Roger F Zabinski,
Rose M Ashley,
Scott R Nichols, PhD,
Sean R Marcsisin,
Siliva Wanis, PharmD,
Sony Mathews,
Stacey S Degarmo,
Swati Verma,
Thai D Truong,
Unnee Ranjan,
Wayne E Seifert
Obinna R Echeozo's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2021 | FDA 483 | Lonza Biologics, Inc. - Form 483, 2021-10-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more